Literature DB >> 7478305

Participation of cAMP and cAMP-dependent protein kinase in beta-adrenoceptor-mediated interleukin-1 beta mRNA induction in cultured microglia.

Y Tomozawa1, K Yabuuchi, T Inoue, M Satoh.   

Abstract

We previously reported evidence of beta-adrenoceptor-mediated induction of IL-1 beta mRNA in the rat hypothalamus. The present in vitro studies using northern blot analysis showed that the beta-adrenoceptor agonist isoproterenol (1 x 10(-8) to 1 x 10(-5) M) caused a marked induction of IL-1 beta mRNA in microglia, but not in astrocytes. This induction was remarkably suppressed by pretreatment of cells with the beta-adrenoceptor antagonist propranolol. These phenomena were confirmed by in situ hybridization with digoxigenin-labelled IL-1 beta RNA probe. Furthermore, dibutyryl cyclicAMP (dbcAMP) (5 x 10(-4) and 5 x 10(-5) M) markedly induced IL-1 beta mRNA in microglia. The intracellular level of cAMP in microglia was elevated in a dose-dependent manner when they were treated with isoproterenol, and this elevation was completely blocked by propranolol. The induction of IL-1 beta mRNA by either isoproterenol or dbcAMP was strongly inhibited by a cAMP-dependent protein kinase inhibitor, H8. These results, taken together, suggest that (1) microglia primarily induce IL-1 beta mRNA by stimulation of beta-adrenoceptors, and (2) cAMP and cAMP-dependent protein kinase presumably participate in a signal transduction mechanism involved in the induction of IL-1 beta mRNA via beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478305     DOI: 10.1016/0168-0102(95)00922-g

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  14 in total

Review 1.  Role of nonsynaptic communication in regulating the immune response.

Authors:  Zsolt Selmeczy; E Sylvester Vizi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Neurochem Int       Date:  2007-06-17       Impact factor: 3.921

2.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

3.  Rat strain differences in restraint stress-induced brain cytokines.

Authors:  V M Porterfield; Z R Zimomra; E A Caldwell; R M Camp; K M Gabella; J D Johnson
Journal:  Neuroscience       Date:  2011-05-18       Impact factor: 3.590

4.  Hydrogen Sulfide Protects Hippocampal Neurons Against Methamphetamine Neurotoxicity Via Inhibition of Apoptosis and Neuroinflammation.

Authors:  Fateme Ghanbari; Mehdi Khaksari; Golamhassan Vaezi; Vida Hojati; Abdolhossein Shiravi
Journal:  J Mol Neurosci       Date:  2018-11-19       Impact factor: 3.444

5.  Role of central beta-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge.

Authors:  John D Johnson; Valerie Cortez; Sarah L Kennedy; Teresa E Foley; Hugo Hanson; Monika Fleshner
Journal:  Brain Behav Immun       Date:  2008-05-12       Impact factor: 7.217

6.  beta2 Adrenergic receptor activation induces microglial NADPH oxidase activation and dopaminergic neurotoxicity through an ERK-dependent/protein kinase A-independent pathway.

Authors:  Li Qian; Xiaoming Hu; Dan Zhang; Amanda Snyder; Hung-Ming Wu; Yachen Li; Belinda Wilson; Ru-Band Lu; Jau-Shyong Hong; Patrick M Flood
Journal:  Glia       Date:  2009-11-15       Impact factor: 7.452

7.  The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.

Authors:  Onofre Combarros; Donald R Warden; Naomi Hammond; Mario Cortina-Borja; Olivia Belbin; Michael G Lehmann; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Rhian Gwilliam; Reinhard Heun; Heike Kölsch; Ignacio Mateo; Abderrahim Oulhaj; Alejandro Arias-Vásquez; Maaike Schuur; Yurii S Aulchenko; M Arfan Ikram; Monique M Breteler; Cornelia M van Duijn; Kevin Morgan; A David Smith; Donald J Lehmann
Journal:  BMC Med Genet       Date:  2010-11-11       Impact factor: 2.103

8.  Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production.

Authors:  Cinzia Dello Russo; Anne I Boullerne; Vitaliy Gavrilyuk; Douglas L Feinstein
Journal:  J Neuroinflammation       Date:  2004-06-30       Impact factor: 8.322

9.  Adenosine A(2A) receptor mediates microglial process retraction.

Authors:  Anna G Orr; Adam L Orr; Xiao-Jiang Li; Robert E Gross; Stephen F Traynelis
Journal:  Nat Neurosci       Date:  2009-06-14       Impact factor: 24.884

Review 10.  Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.

Authors:  Termpanit Chalermpalanupap; Becky Kinkead; William T Hu; Markus P Kummer; Thea Hammerschmidt; Michael T Heneka; David Weinshenker; Allan I Levey
Journal:  Alzheimers Res Ther       Date:  2013-04-29       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.